SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?

Krueger, Karen M; Halasa, Natasha; Ison, Michael G

Krueger, Karen M; Halasa, Natasha; Ison, Michael G.

Krueger KM; Divisions of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Halasa N; Division of Pediatric Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee.
Ison MG; Divisions of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: mgison@northwestern.edu.

Am J Kidney Dis ; 79(2): 162-163, 2022 02.

Article in English | MEDLINE | ID: covidwho-1585733

Subject(s)

COVID-19 Vaccines; COVID-19; Humans; Immunogenicity, Vaccine; Renal Dialysis/adverse effects; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Am J Kidney Dis Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google